By Edward Swift
Date: Monday 26 Oct 2015
LONDON (ShareCast) - (ShareCast News) - Omega Diagnostics Group is expecting to report an 8% increase in its revenue for the first half of the year.
The AIM-listed medical testing company issued a trading update for the six months to 30 September on Monday, before it releases its full interim results in November.
It highlighted that total revenue is £6.15m, up 8% on the previous year and driven by a 20% increase in revenue from its food intolerance business.
The allergy and autoimmune sector was the only part of the business to see a dip in revenue, down 13% to £1.59m.
The company also noted there was an increase in gross profit which covered a rise in management costs in line with its growth plans.
However it is expecting profit before tax to be flat compared with 2014's first half profit of £0.56m.
Chief operating officer Colin King said he's encouraged by the scale of opportunities in the core business units.
"[I] believe we can exploit these in a more aggressive manner.
"As a result of this we have undertaken a review of each unit and are now in the process of developing a three to five year business plan with accelerated growth the key objective."
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 4.15p |
Change Today | 0.050p |
% Change | 1.22 % |
52 Week High | 4.24 |
52 Week Low | 1.73 |
Volume | 495,522 |
Shares Issued | 237.95m |
Market Cap | £9.87m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
13:22 | 94,339 @ 4.24p |
11:35 | 27,512 @ 4.10p |
11:08 | 12,522 @ 4.08p |
10:44 | 71,154 @ 4.20p |
10:34 | 13,432 @ 4.06p |
You are here: research